Developing vaccines to prevent tickborne viral diseases
Vaccines for Prevention of RG3 and RG4 Emerging Tickborne Viral Diseases
This study is working on creating vaccines to help protect people from tickborne viruses, like the Powassan and Heartland viruses, which can make you very sick, especially as these diseases are becoming more common due to changes in the environment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Storrs NIH-funded |
| Lab location | 1 site (Storrs-Mansfield, United States) |
| Project ID | NIH-10892101 on NIH RePORTER |
What this research studies
This research focuses on creating vaccines to protect against emerging tickborne viral diseases, which are becoming more prevalent due to environmental changes. The team at the University of Connecticut is investigating various tickborne viruses, including the Powassan virus and the Heartland virus, which can cause severe health issues like encephalitis and hemorrhagic fever. By understanding these viruses and their transmission through ticks, the researchers aim to develop effective vaccines that can help prevent infections in humans. The project involves collaboration among experts in vaccine development and tickborne viruses to ensure a comprehensive approach to this public health challenge.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas where tickborne diseases are prevalent, particularly those at higher risk of exposure to ticks.
Not a fit: Patients who do not live in tick-infested regions or who have no risk of exposure to tickborne diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of severe tickborne viral diseases in the population.
How similar studies have performed: Other research has shown promise in developing vaccines for tickborne diseases, indicating that this approach has potential for success.
Where this research is happening
Storrs-Mansfield, United States
- University of Connecticut Storrs — Storrs-Mansfield, United States (Active)
Researchers
- Principal investigator: Verardi, Paulo H — University of Connecticut Storrs
- Study coordinator: Verardi, Paulo H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.